The Applications of the Novel Polymeric Fluoropyrimidine F10 in Cancer Treatment: Current Evidence

References

• Heidelberger C , DanenbergPV, MoranRG. Fluorinated pyrimidines and their nucleosides. Adv. Enzymol. Relat. Areas Mol. Biol.54, 58–119 (1983).
   PubMedGoogle Scholar
• Wilson PM , DanenbergPV, JohnstonPG, LenzHJ, LadnerRD. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy. Nat. Rev. Clin. Oncol.11(5), 282–298 (2014).
   PubMed Web of Science ®Google Scholar
• An Q , RobinsP, LindahlT, BarnesDE. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity. Cancer Res.67(3), 940–945 (2007).
   PubMed Web of Science ®Google Scholar
• Bastos DA , RibeiroSC, de FreitasD, HoffPM. Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects. Ther. Adv. Med. Oncol.2(4), 261–272 (2010).
   PubMedGoogle Scholar
• Pardee TS , GomesE, Jennings-GeeJ, CaudellD, GmeinerWH. Unique dual targeting of thymidylate synthase and topoisomerase 1 by FdUMP[10] results in high efficacy against AML and low toxicity. Blood119, 3561–3570 (2012).
   PubMed Web of Science ®Google Scholar
• Pardee TS , StadelmanK, Jennings-GeeJ, CaudellDL, GmeinerWH. The poison oligonucleotide F10 is highly proliferative against acure lympoblastic leukemia while sparing normal hemtopoietic cells. Oncotarget5(12), 4170–4179 (2014).
   PubMedGoogle Scholar
• Gmeiner WH , Lema-TomeC, GiboD, Jennings-GeeJ, MilliganC, DebinskiW. Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors. J. Neurooncol.116(3), 447–454 (2014).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH , BourlandJD, HatcherHC, SmithTL, D’AgostinoRBJr, BlackstockW. F10 inhibits growth of PC3 xenografts and enhances the effects of radiation therapy. JSM Clin. Oncol. Res.2(4), 1028 (2014).
   PubMedGoogle Scholar
• Longley DB , HarkinDP, JohnstonPG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer.3(5), 330–338 (2003).
   PubMed Web of Science ®Google Scholar
• Carreras CW , SantiDV. The catalytic mechanism and structure of thymidylate synthase. Annu. Rev. Biochem.64, 721–762 (1995).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH . Novel chemical strategies for thymidylate synthase inhibition. Curr. Med. Chem.12(2), 191–202 (2005).
   PubMed Web of Science ®Google Scholar
• Ciaparrone M , QuirinoM, SchinzariGet al. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Oncology70(5), 366–377 (2006).
   PubMed Web of Science ®Google Scholar
• Diasio RB , JohnsonMR. The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil. Pharmacology61(3), 199–203 (2000).
   PubMed Web of Science ®Google Scholar
• Matsubara I , KamiyaJ, ImaiS. Cardiotoxic effects of 5-fluorouracil in the guinea pig. Jpn. J. Pharmacol.30(6), 871–879 (1980).
   PubMedGoogle Scholar
• Yamashita K , YadaH, AriyoshiT. Neurotoxic effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on dogs. J. Toxicol. Sci.29(2), 155–166 (2004).
   PubMedGoogle Scholar
• Gusella M , FrigoAC, BolzonellaCet al. Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. Br. J. Cancer100(10), 1549–1557 (2009).
   PubMed Web of Science ®Google Scholar
• Wolmark N , RocketteH, MamounasEet al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes’ B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J. Clin. Oncol.17(11), 3553–3559 (1999).
   PubMed Web of Science ®Google Scholar
• Noordhuis P , HolwerdaU, Van der WiltCLet al. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann. Oncol.15(7), 1025–1032 (2004).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH , TrumpE, WeiC. Enhanced DNA-directed effects of FdUMP[10] compared with 5FU. Nucleosides Nucleotides Nucleic Acids23(1–2), 401–410 (2004).
   PubMed Web of Science ®Google Scholar
• Shaw JP , KentK, BirdJ, FishbackJ, FroehlerB. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res.19(4), 747–750 (1991).
   PubMed Web of Science ®Google Scholar
• Bijnsdorp IV , ComijnEM, PadronJM, GmeinerWH, PetersGJ. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition. Oncol Rep.18(1), 287–291 (2007).
   PubMed Web of Science ®Google Scholar
• Liao ZY , SordetO, ZhangHLet al. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes. Cancer Res.65(11), 4844–4851 (2005).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH , ReinholdWC, PommierY. Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons. Mol. Cancer Ther.9(12), 3105–3114 (2010).
   PubMed Web of Science ®Google Scholar
• Zhao Q , SongX, WaldschmidtT, FisherE, KriegAM. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood88(5), 1788–1795 (1996).
   PubMed Web of Science ®Google Scholar
• Chu E , VoellerD, KoellerDMet al. Identification of an RNA binding site for human thymidylate synthase. Proc. Natl Acad. Sci. USA90(2), 517–521 (1993).
   PubMed Web of Science ®Google Scholar
• Liu J , SchmitzJC, LinXet al. Thymidylate synthase as a translational regulator of cellular gene expression. Biochim. Biophys. Acta1587(2–3), 174–182 (2002).
   PubMed Web of Science ®Google Scholar
• Kamm YJ , PetersGJ, HullWE, PuntCJ, HeerschapA. Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma. Br. J. Cancer89(4), 754–762 (2003).
   PubMed Web of Science ®Google Scholar
• Curtin NJ , HarrisAL, AherneGW. Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res.51(9), 2346–2352 (1991).
   PubMed Web of Science ®Google Scholar
• Dusenbury CE , DavisMA, LawrenceTS, MaybaumJ. Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells. Mol. Pharmacol.39(3), 285–289 (1991).
   PubMed Web of Science ®Google Scholar
• Jennings-Gee J , PardeeTS, GmeinerWH. Replication-dependent irreversible topoisomerase 1 poisoning is responsible for FdUMP[10] anti-leukemic activity. Exp. Hematol.41(2), 180–188 (2013).
   PubMed Web of Science ®Google Scholar
• Pommier Y . Drugging topoisomerases: lessons and challenges. ACS Chem. Biol.8(1), 82–95 (2013).
   PubMed Web of Science ®Google Scholar
• Shoemaker RH . The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer6(10), 813–823 (2006).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH , YuS, PonRT, PourquierP, PommierY. Structural basis for topoisomerase I inhibition by nucleoside analogs. Nucleosides Nucleotides Nucleic Acids22(5–8), 653–658 (2003).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH . Antimetabolite incorporation into DNA: structural and thermodynamic basis for anticancer activity. Biopolymers65(3), 180–189 (2002).
   PubMed Web of Science ®Google Scholar
• Pommier Y . Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer6(10), 789–802 (2006).
   PubMed Web of Science ®Google Scholar
• Desai SD , ZhangH, Rodriguez-BaumanAet al. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol. Cell Biol.23(7), 2341–2350 (2003).
   PubMed Web of Science ®Google Scholar
• Lin CP , BanY, LyuYL, LiuLF. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks. J. Biol. Chem.284(41), 28084–28092 (2009).
   PubMed Web of Science ®Google Scholar
• Khodursky A , GuzmanEC, HanawaltPC. Thymineless death lives on: new insights into a classic phenomenon. Annu. Rev. Microbiol.69, 247–263 (2015).
   PubMed Web of Science ®Google Scholar
• Hanawalt PC . A balanced perspective on unbalanced growth and thymineless death. Front. Microbiol.6, 504 (2015).
   PubMed Web of Science ®Google Scholar
• Grogan BC , ParkerJB, GuminskiAF, StiversJT. Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA. Biochemistry50(5), 618–627 (2011).
   PubMed Web of Science ®Google Scholar
• Seiple L , JarugaP, DizdarogluM, StiversJT. Linking uracil base excision repair and 5-fluorouracil toxicity in yeast. Nucleic Acids Res.34(1), 140–151 (2006).
   PubMed Web of Science ®Google Scholar
• Houghton JA , HarwoodFG, TillmanDM. Thymineless death in colon carcinoma cells is mediated via fas signaling. Proc. Natl Acad. Sci. USA94(15), 8144–8149 (1997).
   PubMed Web of Science ®Google Scholar
• Tillman DM , PetakI, HoughtonJA. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Clin. Cancer Res.5(2), 425–430 (1999).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH , Jennings-GeeJ, StuartCH, PardeeTS. Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway. Leuk. Res.39(2), 229–235 (2015).
   PubMed Web of Science ®Google Scholar
• Feldman EJ , GergisU. Management of refractory acute myeloid leukemia: re-induction therapy or straight to transplantation?Curr. Hematol. Malig. Rep.7(1), 74–77 (2012).
   PubMed Web of Science ®Google Scholar
• Wielinga PR , WesterhoffHV, LankelmaJ. The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells. Eur. J. Biochem.267(3), 649–657 (2000).
   PubMedGoogle Scholar
• Veuger MJ , HondersMW, SpoelderHE, WillemzeR, BargeRM. Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines. Leuk. Res.27(5), 445–453 (2003).
   PubMed Web of Science ®Google Scholar
• Pardee TS , ZuberJ, LoweSW. Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner. Exp. Hematol.39(4), 473–485 (2011).
   PubMed Web of Science ®Google Scholar
• Pardee TS . Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction. PLoS ONE7(8), e43185 (2012).
   PubMed Web of Science ®Google Scholar
• Zuber J , RadtkeT, PardeeTSet al. Mouse models of human AML accurately predict chemotherapy response. Genes Dev.23(7), 877–889 (2009).
   PubMed Web of Science ®Google Scholar
• Pritchard DM , WatsonAJ, PottenCS, JackmanAL, HickmanJA. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc. Natl Acad. Sci. USA94(5), 1795–1799 (1997).
   PubMed Web of Science ®Google Scholar
• Lu H , ZhuS, QianLet al. Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity. Blood119(21), 4868–4877 (2012).
   PubMed Web of Science ®Google Scholar
• Krug U , BuchnerT, BerdelWE, Muller-TidowC. The treatment of elderly patients with acute myeloid leukemia. Dtsch Arztebl. Int.108(51–52), 863–870 (2011).
   PubMed Web of Science ®Google Scholar
• Ottmann OG , PfeiferH. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Hematology. Am. Soc. Hematol. Educ. Program371–381 (2009).
   PubMed Web of Science ®Google Scholar
• Weiss M , MaslakP, FeldmanEet al. Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. J. Clin. Oncol.14(9), 2480–2485 (1996).
   PubMed Web of Science ®Google Scholar
• Oriol A , VivesS, Hernandez-RivasJMet al. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica95(4), 589–596 (2010).
   PubMed Web of Science ®Google Scholar
• Agnihotri S , BurrellKE, WolfAet al. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch. Immunol. Ther. Exp. (Warsz)61(1), 25–41 (2013).
   PubMed Web of Science ®Google Scholar
• van Tellingen O , Yetkin-ArikB, de GooijerMC, WesselingP, WurdingerT, de VriesHE. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist. Update19, 1–12 (2015).
   PubMed Web of Science ®Google Scholar
• Pandya H , GiboDM, GargS, KridelS, DebinskiW. An interleukin 13 receptor alpha 2-specific peptide homes to human glioblastoma multiforme xenografts. Neuro Oncol.14(1), 6–18 (2012).
   PubMed Web of Science ®Google Scholar
• Miura K , KinouchiM, IshidaKet al. 5-FU metabolism in cancer and orally-administrable 5-fu drugs. Cancers (Basel)2(3), 1717–1730 (2010).
   PubMedGoogle Scholar
• Oudard S . Progress in emerging therapies for advanced prostate cancer. Cancer Treat. Rev.39(3), 275–289 (2013).
   PubMed Web of Science ®Google Scholar
• Berlin JD , PropertKJ, TrumpDet al. 5-fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group Phase II study (E1889). Am J. Clin. Oncol.21(2), 171–176 (1998).
   PubMed Web of Science ®Google Scholar
• Tannock IF , de WitR, BerryWRet al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N. Engl. J. Med.351(15), 1502–1512 (2004).
   PubMed Web of Science ®Google Scholar
• Lawrence TS , MaybaumJ. Fluoropyrimidines as radiation sensitizers. Semin. Radiat. Oncol.3(1), 20–28 (1993).
   PubMedGoogle Scholar
• Martin NE , D’AmicoAV. Progress and controversies: radiation therapy for prostate cancer. CA Cancer J. Clin.64(6), 389–407 (2014).
   PubMed Web of Science ®Google Scholar